Literature DB >> 21872848

Early-life forebrain glucocorticoid receptor overexpression increases anxiety behavior and cocaine sensitization.

Qiang Wei1, Hugh M Fentress, Mary T Hoversten, Limei Zhang, Elaine K Hebda-Bauer, Stanley J Watson, Audrey F Seasholtz, Huda Akil.   

Abstract

BACKGROUND: Genetic factors and early-life adversity are critical in the etiology of mood disorders and substance abuse. Because of their role in the transduction of stress responses, glucocorticoid hormones and their receptors could serve as both genetic factors and mediators of environmental influences. We have shown that constitutive overexpression of the glucocorticoid receptor (GR) in forebrain results in increased emotional reactivity and lability in mice. Here, we asked whether there was a critical period for the emergence of this phenotype.
METHODS: We generated a mouse line with inducible GR overexpression specifically in forebrain. Anxiety-like behaviors and cocaine-induced sensitization were assessed in adult mice following GR overexpression during different periods in development. The molecular basis of the behavioral phenotype was examined using microarray analyses of dentate gyrus and nucleus accumbens.
RESULTS: Transient overexpression of GR during early life led to increased anxiety and cocaine sensitization, paralleling the phenotype of lifelong GR overexpression. This increased emotional reactivity was not observed when GR overexpression was induced after weaning. Glucocorticoid receptor overexpression in early life is sufficient to alter gene expression patterns for the rest of the animal's life, with dentate gyrus being more responsive than nucleus accumbens. The altered transcripts are implicated in GR and axonal guidance signaling in dentate gyrus and dopamine receptor signaling in nucleus accumbens.
CONCLUSIONS: Transient overexpression of GR early in life is both necessary and sufficient for inducing transcriptome-wide changes in the brain and producing a lifelong increase in vulnerability to anxiety and drugs of abuse.
Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872848      PMCID: PMC3245807          DOI: 10.1016/j.biopsych.2011.07.009

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  46 in total

Review 1.  Stress, adaptation, and disease. Allostasis and allostatic load.

Authors:  B S McEwen
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

Review 2.  Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis.

Authors:  J P Herman; W E Cullinan
Journal:  Trends Neurosci       Date:  1997-02       Impact factor: 13.837

3.  DNA binding of the glucocorticoid receptor is not essential for survival.

Authors:  H M Reichardt; K H Kaestner; J Tuckermann; O Kretz; O Wessely; R Bock; P Gass; W Schmid; P Herrlich; P Angel; G Schütz
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

4.  Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function.

Authors:  A Montkowski; N Barden; C Wotjak; I Stec; J Ganster; M Meaney; M Engelmann; J M Reul; R Landgraf; F Holsboer
Journal:  J Neuroendocrinol       Date:  1995-11       Impact factor: 3.627

5.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

6.  Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions.

Authors:  Stephanie Ridder; Sabine Chourbaji; Rainer Hellweg; Alexandre Urani; Christiane Zacher; Wolfgang Schmid; Mathias Zink; Heide Hörtnagl; Herta Flor; Fritz A Henn; Günther Schütz; Peter Gass
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

7.  Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: effects of diazepam and FG-7142.

Authors:  J Rochford; S Beaulieu; I Rousse; J R Glowa; N Barden
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

Review 8.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

9.  Overexpressing the glucocorticoid receptor in forebrain causes an aging-like neuroendocrine phenotype and mild cognitive dysfunction.

Authors:  Qiang Wei; Elaine K Hebda-Bauer; Amy Pletsch; Jie Luo; Mary T Hoversten; Andrew J Osetek; Simon J Evans; Stanley J Watson; Audrey F Seasholtz; Huda Akil
Journal:  J Neurosci       Date:  2007-08-15       Impact factor: 6.167

Review 10.  Gene-environment interactions in psychiatry: joining forces with neuroscience.

Authors:  Avshalom Caspi; Terrie E Moffitt
Journal:  Nat Rev Neurosci       Date:  2006-07       Impact factor: 34.870

View more
  19 in total

1.  Glucocorticoid sensitizers Bag1 and Ppid are regulated by adolescent stress in a sex-dependent manner.

Authors:  Chase H Bourke; Madiha Q Raees; Sanjana Malviya; Cory A Bradburn; Elisabeth B Binder; Gretchen N Neigh
Journal:  Psychoneuroendocrinology       Date:  2012-05-29       Impact factor: 4.905

2.  Sepsis survivor mice exhibit a behavioral endocrine syndrome with ventral hippocampal dysfunction.

Authors:  Joanna L Spencer-Segal; Benjamin H Singer; Klaudia Laborc; Khyati Somayaji; Stanley J Watson; Theodore J Standiford; Huda Akil
Journal:  Psychoneuroendocrinology       Date:  2020-04-13       Impact factor: 4.905

Review 3.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

4.  Neonatal fibroblast growth factor treatment enhances cocaine sensitization.

Authors:  Sarah M Clinton; Cortney A Turner; Shelly B Flagel; Danielle N Simpson; Stanley J Watson; Huda Akil
Journal:  Pharmacol Biochem Behav       Date:  2012-11       Impact factor: 3.533

Review 5.  Revisiting the Stress Concept: Implications for Affective Disorders.

Authors:  Bruce S McEwen; Huda Akil
Journal:  J Neurosci       Date:  2020-01-02       Impact factor: 6.167

6.  Optimization and evaluation of fluorescence in situ hybridization chain reaction in cleared fresh-frozen brain tissues.

Authors:  Vivek Kumar; David M Krolewski; Elaine K Hebda-Bauer; Aram Parsegian; Brian Martin; Matthew Foltz; Huda Akil; Stanley J Watson
Journal:  Brain Struct Funct       Date:  2021-01-02       Impact factor: 3.270

7.  Impact of Exposure to Childhood Maltreatment on Transitions to Alcohol Dependence in Women and Men.

Authors:  Lindsay M S Oberleitner; Philip H Smith; Andrea H Weinberger; Carolyn M Mazure; Sherry A McKee
Journal:  Child Maltreat       Date:  2015-06-30

8.  Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder.

Authors:  Bhaskar Roy; Michael Dunbar; Richard C Shelton; Yogesh Dwivedi
Journal:  Neuropsychopharmacology       Date:  2016-08-31       Impact factor: 7.853

Review 9.  Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy.

Authors:  Sherice Williams; Chaitali Ghosh
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

Review 10.  Treatment resistant depression: A multi-scale, systems biology approach.

Authors:  Huda Akil; Joshua Gordon; Rene Hen; Jonathan Javitch; Helen Mayberg; Bruce McEwen; Michael J Meaney; Eric J Nestler
Journal:  Neurosci Biobehav Rev       Date:  2017-08-30       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.